-
Je něco špatně v tomto záznamu ?
Měl by být Gleasonův systém klasifikace karcinomu prostaty modifikován tak, aby zohledňoval terciární komponenty vysokého stupně? Systematický přehled a metaanalýza
[Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis]
Patricia Harnden, Mike D. Shelley, Bernadette Coles, John Staffurth, Malcolm D. Mason ; Jiří Štipl (přeložil)
Jazyk čeština Země Česko
- MeSH
- buněčné jádro patologie MeSH
- lidé MeSH
- lokální recidiva nádoru prevence a kontrola MeSH
- nádory prostaty chirurgie krev patologie MeSH
- prognóza MeSH
- progrese nemoci MeSH
- prostatektomie MeSH
- prostatický specifický antigen krev MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
The Gleason system for grading prostate cancer assigns a score on the basis of the most prevalent and second most prevalent grade. Several studies have investigated the clinical significance of a tertiary grade in radical prostatectomy samples. A systematic search of the published work identified seven studies that reported the prognostic value of a tertiary Gleason grade. Three studies correlated the presence of a tertiary grade with pathological stage, and six with prostate-specific antigen recurrence or clinical progression. In the small number of studies available, the frequency of a tertiary grade was consistently higher in samples characterised with pathological variables of poor outcome, such as extra-prostatic extension and positive surgical margins, but not lymph-node metastases. In five studies the presence of a tertiary grade increased the risk of prostate-specific antigen recurrence after radical prostatectomy by a factor of 2.5. However, modification of the Gleason score to include a tertiary grade in Gleason 4+3 tumours might overestimate the risk of seminal-vesicle or lymph-node invasion. This systematic review has established the association of a tertiary grade with poorer outcome than that associated with no tertiary grade. A tertiary grade should, therefore, be included in the pathological reporting of prostate cancer and be considered in the interpretation and design of clinical trials. However, all studies assessed for this review were retrospective, potentially affected by selection bias, and based on radical prostatectomy samples or transurethral resections rather than biopsy samples. Therefore, more evidence is needed to warrant the adaptation of the Gleason system to account for the presence of a tertiary grade, especially when scoring prostatic biopsies and applying predictive algorithms.
Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis
Lit.: 52
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07512779
- 003
- CZ-PrNML
- 005
- 20180611073203.0
- 008
- 081121s2007 xr e cze||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Harnden, Patricia
- 245 10
- $a Měl by být Gleasonův systém klasifikace karcinomu prostaty modifikován tak, aby zohledňoval terciární komponenty vysokého stupně? Systematický přehled a metaanalýza / $c Patricia Harnden, Mike D. Shelley, Bernadette Coles, John Staffurth, Malcolm D. Mason ; Jiří Štipl (přeložil)
- 246 11
- $a Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis
- 314 __
- $a Cancer Research UK Clinical Centre, St James's University Hospital, Leeds
- 504 __
- $a Lit.: 52
- 520 9_
- $a The Gleason system for grading prostate cancer assigns a score on the basis of the most prevalent and second most prevalent grade. Several studies have investigated the clinical significance of a tertiary grade in radical prostatectomy samples. A systematic search of the published work identified seven studies that reported the prognostic value of a tertiary Gleason grade. Three studies correlated the presence of a tertiary grade with pathological stage, and six with prostate-specific antigen recurrence or clinical progression. In the small number of studies available, the frequency of a tertiary grade was consistently higher in samples characterised with pathological variables of poor outcome, such as extra-prostatic extension and positive surgical margins, but not lymph-node metastases. In five studies the presence of a tertiary grade increased the risk of prostate-specific antigen recurrence after radical prostatectomy by a factor of 2.5. However, modification of the Gleason score to include a tertiary grade in Gleason 4+3 tumours might overestimate the risk of seminal-vesicle or lymph-node invasion. This systematic review has established the association of a tertiary grade with poorer outcome than that associated with no tertiary grade. A tertiary grade should, therefore, be included in the pathological reporting of prostate cancer and be considered in the interpretation and design of clinical trials. However, all studies assessed for this review were retrospective, potentially affected by selection bias, and based on radical prostatectomy samples or transurethral resections rather than biopsy samples. Therefore, more evidence is needed to warrant the adaptation of the Gleason system to account for the presence of a tertiary grade, especially when scoring prostatic biopsies and applying predictive algorithms.
- 650 _2
- $a buněčné jádro $x patologie $7 D002467
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lokální recidiva nádoru $x prevence a kontrola $7 D009364
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a prostatický specifický antigen $x krev $7 D017430
- 650 _2
- $a prostatektomie $7 D011468
- 650 _2
- $a nádory prostaty $x chirurgie $x krev $x patologie $7 D011471
- 700 1_
- $a Shelley, Mike D.
- 700 1_
- $a Coles, Bernadette
- 700 1_
- $a Staffurth, John
- 700 1_
- $a Mason, Malcolm $7 xx0225139
- 700 1_
- $a Štipl, Jiří. $7 xx0244386
- 773 0_
- $w MED00012637 $t The lancet oncology CZ $g Roč. 6, č. 3 (2007), s. 246-255 $x 1213-9432
- 787 18
- $w bmc07512780 $i Recenze v: $t Komentář [k článku Měl by být Gleasonův systém klasifikace karcinomu prostaty modifikován tak, aby zohledňoval terciární komponenty vysokého stupně? Systematický přehled a metaanalýza]
- 910 __
- $a ABA008 $b B 2277 $c 1153 b $y 1 $z 0
- 990 __
- $a 20081118143934 $b ABA008
- 991 __
- $a 20180611073413 $b ABA008
- 999 __
- $a ok $b bmc $g 628373 $s 480820
- BAS __
- $a 3
- BMC __
- $a 2007 $b 6 $c 3 $d 246-255 $i 1213-9432 $m The lancet oncology CZ $x MED00012637
- LZP __
- $a 2008-20/mkme